BDNF (Brain-Derived Neurotrophic Factor): What It Is, Why It Matters, and How to Increase It

BDNF — brain-derived neurotrophic factor — is arguably the single most important protein for long-term brain health. It governs whether neurons survive, how efficiently they communicate, and whether your brain can physically rewire itself in response to new experiences. If you want to understand cognitive performance, depression, neurodegeneration, or healthy ageing at a mechanistic level, BDNF is where that conversation begins.

This guide covers what brain-derived neurotrophic factor does, what suppresses it, and — most importantly — the evidence-based interventions that reliably increase it.

What Is BDNF?

Brain-derived neurotrophic factor is a member of the neurotrophin family of growth factors, alongside nerve growth factor (NGF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4). It is the most abundant and extensively studied neurotrophin in the mammalian brain.

BDNF is synthesised and secreted predominantly in the:

Hippocampus — the primary site of memory consolidation and adult neurogenesis
Prefrontal cortex — executive function, decision-making, working memory
Basal forebrain — cholinergic neuron maintenance; relevant to Alzheimer's pathology
Cerebellum — motor learning and coordination

It is released in an activity-dependent manner: when neurons fire, BDNF secretion increases. This creates a self-reinforcing loop — cognitive engagement stimulates BDNF, which in turn strengthens the neural circuits driving that engagement.

How BDNF Works: TrkB and p75NTR Receptor Signalling

BDNF exerts its effects primarily through two receptor types:

TrkB (Tropomyosin receptor kinase B) is the high-affinity receptor responsible for the majority of BDNF's beneficial effects. When BDNF binds TrkB, it activates downstream signalling cascades — principally the MAPK/ERK and PI3K/Akt pathways — that promote neuron survival, dendritic growth, and synaptic protein synthesis.

p75NTR is a lower-affinity pan-neurotrophin receptor. Its role is context-dependent: in some circumstances it promotes cell survival synergistically with TrkB; in others (particularly under low BDNF conditions) it can promote apoptosis.

The balance between these receptor systems partly explains why BDNF has such nuanced effects depending on brain region and developmental context.

Why Brain-Derived Neurotrophic Factor Matters for Brain Health

Neurogenesis — Growing New Neurons in Adulthood

One of the most consequential discoveries in modern neuroscience is that the adult human brain continues to produce new neurons, primarily in the hippocampal dentate gyrus. This process — adult hippocampal neurogenesis — is critically dependent on BDNF. Without adequate BDNF signalling, newly born neurons fail to integrate into existing circuits and undergo apoptosis before they can contribute to function.

This matters enormously for learning and memory. The hippocampus encodes new episodic memories by incorporating novel information into existing networks. Neurogenesis provides the structural substrate for that process. BDNF is the molecular switch that determines whether it happens.

Long-Term Potentiation — The Cellular Basis of Learning

Long-term potentiation (LTP) is the process by which repeated neuronal co-activation strengthens synaptic connections — the cellular mechanism underlying learning. BDNF is not merely permissive for LTP; it is actively required for its late phase (L-LTP), which involves new protein synthesis and lasting structural changes at the synapse.

When BDNF binds TrkB at the synapse, it triggers the production of key plasticity proteins including Arc, GluR1 AMPA receptor subunits, and PSD-95. These proteins physically expand and reinforce the synapse. Low BDNF means weaker, less persistent synaptic strengthening — which translates directly to impaired acquisition of new skills and memories.

Neuroprotection — Keeping Existing Neurons Alive

BDNF acts as a survival factor for mature neurons. It suppresses pro-apoptotic proteins (including Bad and Bax) and upregulates anti-apoptotic proteins (Bcl-2, Bcl-xL) through TrkB-mediated Akt signalling. It also reduces excitotoxicity — the neuronal death caused by excessive glutamate receptor activation — which is a major driver of neuronal loss in stroke, traumatic brain injury, and neurodegenerative disease.

Maintaining adequate BDNF levels throughout life is one of the best-understood mechanisms for preserving the neurons you already have.

Mood Regulation — The Neurotrophic Hypothesis of Depression

The relationship between BDNF and depression is one of the most important in psychiatry. Post-mortem studies consistently show reduced BDNF in the hippocampus and prefrontal cortex of individuals who died with major depressive disorder. Animal models with reduced BDNF signalling display depression-like behaviour. Human studies show lower serum BDNF in depressed patients, correlating with symptom severity.

This has given rise to the neurotrophic hypothesis of depression: that depression is at least partly a disease of insufficient BDNF-mediated neuroplasticity, and that the hippocampal atrophy observed in chronic depression reflects a failure of neurotrophin-dependent neuron survival and neurogenesis.

Critically, virtually all effective antidepressant treatments — SSRIs, SNRIs, TCAs, electroconvulsive therapy, ketamine — increase BDNF expression in the hippocampus. Serum BDNF increases with antidepressant response, and this increase tracks remission. BDNF is therefore not just a biomarker of depression; it appears to be mechanistically central to recovery.

The BDNF Val66Met single nucleotide polymorphism (SNP) is worth noting: individuals carrying the Met allele secrete less BDNF in response to neural activity (due to impaired trafficking of BDNF to secretory vesicles) and have higher rates of anxiety, depression, and poorer episodic memory. If you carry this variant — testable via consumer genomics — maximising upstream BDNF production becomes especially important.

Cognitive Reserve and Ageing

BDNF levels decline naturally with age, paralleling the cognitive changes seen in normal ageing: slower processing speed, reduced working memory capacity, and greater difficulty encoding new information. Higher baseline BDNF is associated with slower age-related cognitive decline and larger hippocampal volume in older adults.

In Alzheimer's disease, BDNF reduction is one of the earliest detectable molecular changes, preceding overt amyloid plaque formation in some studies. Reduced BDNF-TrkB signalling impairs the clearance of amyloid-beta and tau phosphorylation regulation — both hallmarks of Alzheimer's pathology. The TrkB signalling pathway is currently one of the most actively pursued drug targets in Alzheimer's research.

What Depletes BDNF

Before discussing how to raise BDNF, it is worth understanding what suppresses it — because many of these factors are ubiquitous in modern life.

Chronic stress and elevated cortisol are the most potent suppressors of brain-derived neurotrophic factor. Glucocorticoid receptors in the hippocampus, when chronically activated by sustained cortisol, directly repress BDNF gene transcription. This is the mechanism linking chronic psychological stress to hippocampal atrophy and depression risk. See the detailed breakdown in chronic stress and cortisol damage to the hippocampus.

Sedentary behaviour is strongly associated with reduced BDNF at the population level. Physical inactivity removes one of the most potent known BDNF-stimulating signals — the exercise-induced molecular cascade described below.

Sleep deprivation and poor sleep architecture significantly suppress BDNF. Synthesis peaks during slow-wave (deep) sleep. Chronic restriction of sleep — even to six hours per night — produces measurable reductions in serum BDNF within days.

High-sugar and ultra-processed diets impair BDNF signalling through multiple mechanisms: insulin resistance reduces TrkB receptor sensitivity, advanced glycation end-products promote neuroinflammation, and refined carbohydrate-driven insulin spikes suppress AMPK — a key upstream activator of BDNF transcription.

Mitochondrial dysfunction creates a vicious cycle with BDNF: reduced ATP availability suppresses BDNF synthesis and activity-dependent secretion, while falling BDNF in turn reduces the mitochondrial biogenesis that would otherwise restore ATP supply. The full scope of this bidirectional relationship — and the interventions that target it — is covered in the mitochondria and cognitive performance overview.

Social isolation reduces hippocampal BDNF in both animal and observational human studies. The mechanism involves reduced activity-dependent secretion and increased cortisol from chronic social stress.

Ageing produces a progressive decline in BDNF expression driven by epigenetic silencing of the BDNF promoter, reduced oestrogen (which normally upregulates BDNF), and accumulated oxidative stress.

Neuroinflammation — whether from systemic illness, poor gut health, or environmental toxins — activates microglial inflammatory cascades that downregulate BDNF production in neighbouring astrocytes and neurons. The gut-brain axis is a particularly relevant pathway here: microbiome dysbiosis reduces hippocampal BDNF expression in animal models, while probiotic and dietary interventions that restore gut health partially reverse this suppression.

Evidence-Based Ways to Increase BDNF

1. Exercise — The Strongest and Most Consistent BDNF Intervention

No intervention has more replicated, robust evidence for increasing BDNF than aerobic exercise. A single bout of moderate-to-vigorous aerobic exercise produces measurable increases in serum BDNF within 10–20 minutes that persist for several hours. Chronic aerobic training increases resting baseline BDNF and expands hippocampal volume — the latter demonstrated in randomised controlled trials in both young adults and older populations.

The molecular mechanism is now well characterised. During sustained aerobic activity:

Working muscles produce lactate, which crosses the blood-brain barrier
Lactate stimulates PGC-1α expression in hippocampal neurons
PGC-1α drives expression of FNDC5 (fibronectin type III domain-containing protein 5)
FNDC5 is cleaved to release irisin, which directly upregulates BDNF expression in hippocampal neurons
Concurrently, exercise increases IGF-1 and VEGF, both of which contribute to the BDNF response

For practical application:

Zone 2 cardio (conversational pace, roughly 60–70% max heart rate, 30–45 minutes) produces the largest and most sustained BDNF increases in most studies. This intensity maximises lactate utilisation and PGC-1α signalling without the stress hormone response that can partially blunt the effect.
HIIT (high-intensity interval training) produces acute BDNF spikes and has meaningful evidence, though the chronic elevation may be somewhat smaller than Zone 2 in head-to-head comparisons.
Resistance training has supportive evidence — systematic reviews show moderate positive effects — but effect sizes are generally smaller than aerobic training for BDNF specifically.

A reasonable synthesis: 3–4 sessions per week of Zone 2 cardio (cycling, running, rowing, swimming) provides the most reliable BDNF stimulus, with HIIT or resistance training as useful supplements rather than replacements.

2. Lion's Mane Mushroom

Lion's Mane (Hericium erinaceus) contains two classes of bioactive compounds — hericenones (from the fruiting body) and erinacines (from the mycelium) — that stimulate the synthesis of nerve growth factor (NGF). While NGF and BDNF are distinct neurotrophins, they share substantial downstream signalling overlap through the TrkA/TrkB receptor families and through shared transcription factors including CREB.

Several studies in older adults with mild cognitive impairment have shown improvements in cognitive test scores following Lion's Mane supplementation at doses of 750mg–3g daily. The proposed mechanism is NGF upregulation in the hippocampus and olfactory bulb, with secondary effects on BDNF via NGF-BDNF cross-talk.

Lion's Mane is one of the best-characterised supplements in this space, with a favourable safety profile and meaningful — if not yet definitive — human evidence. A full mechanistic breakdown is available in the dedicated article on Lion's Mane, NGF, and cognitive enhancement.

Practical note: Full-spectrum fruiting body extract standardised to beta-glucan content, or dual-extract preparations including mycelium, are preferable to products that are predominantly mycelium grown on grain substrate.

3. Intermittent Fasting and Caloric Restriction

Fasting activates AMPK (AMP-activated protein kinase), an energy-sensing enzyme that upregulates BDNF gene expression through multiple transcription factors. Additionally, extended fasting shifts the brain toward ketone metabolism — and beta-hydroxybutyrate (BHB), the predominant ketone body, directly increases hippocampal BDNF expression, plausibly by inhibiting histone deacetylases (HDACs) and thereby reopening epigenetically silenced BDNF promoter regions.

Human studies on 16:8 time-restricted eating (16 hours fasted, 8-hour eating window) show statistically significant increases in serum BDNF compared to unrestricted eating in trials of 8–12 weeks. Alternate day fasting and 5:2 protocols show similar or larger effects, though compliance is lower.

This intervention stacks particularly well with morning exercise: a Zone 2 cardio session performed in the fasted state amplifies both the exercise-induced BDNF signal and the fasting-induced AMPK/ketone pathway.

4. Cold Exposure

Acute cold water immersion triggers a large norepinephrine (noradrenaline) release — studies at 14°C water temperature report two- to three-fold increases in plasma norepinephrine. Norepinephrine acts on beta-adrenergic receptors in hippocampal neurons to upregulate BDNF mRNA transcription via CREB activation.

The evidence for cold exposure as a direct BDNF supplement strategy is less extensive than for exercise or fasting, but the mechanistic rationale is solid and the norepinephrine response is one of the most reproducible acute physiological effects of cold immersion. Even cold showers (approximately 10–15°C for 2–3 minutes) produce measurable norepinephrine increases.

Cold exposure also complements the broader BDNF protocol by reducing systemic inflammation and improving sleep quality — both of which further support BDNF expression.

5. Sleep Optimisation

BDNF synthesis is strongly tied to sleep architecture. Slow-wave sleep (SWS, or N3 deep sleep) is the phase during which BDNF expression peaks and where much of the synaptic consolidation dependent on BDNF occurs. Chronic sleep restriction — defined in most studies as less than 7 hours per night — suppresses serum BDNF significantly within one week, with the reduction partially persisting even after recovery sleep.

Practical priorities for supporting BDNF via sleep:

Consistent sleep and wake times to anchor circadian rhythm, which governs SWS proportion
Reducing alcohol, which fragments sleep architecture and severely suppresses SWS
Keeping the bedroom cool (18–19°C) to facilitate entry into deep sleep
Avoiding blue light exposure for 1–2 hours before sleep
Treating obstructive sleep apnoea — OSA is among the most under-recognised causes of BDNF suppression and cognitive impairment

6. Dietary Support for BDNF

No single food dramatically increases BDNF in isolation, but several dietary components have meaningful mechanistic evidence and are worth prioritising as part of a BDNF supplement strategy.

Omega-3 DHA (docosahexaenoic acid) is structurally incorporated into neuronal cell membranes and TrkB receptor-containing lipid rafts. DHA deficiency impairs TrkB receptor clustering and reduces BDNF signalling efficiency even when BDNF protein levels are adequate. Meta-analyses of omega-3 supplementation show modest but consistent increases in BDNF, with larger effects in populations deficient at baseline. Target dose: 1–2g DHA daily from fish oil or algal oil.

Curcumin crosses the blood-brain barrier and activates CREB, a key transcription factor for BDNF gene expression. Multiple animal studies and several human trials show curcumin increases BDNF. The major limitation is bioavailability — native curcumin is poorly absorbed. Formulations with piperine (bioperine), phospholipid complexes (Meriva), or nanoparticulate delivery significantly improve absorption.

Resveratrol activates SIRT1, a NAD+-dependent deacetylase that upregulates BDNF gene transcription. Evidence is primarily from animal studies, with a smaller human literature. More relevant for those following a caloric restriction or fasting protocol where NAD+ metabolism is already activated.

Flavonoids and polyphenols — particularly from blueberries, dark chocolate, and green tea — have evidence for activating TrkB signalling pathways and reducing neuroinflammation. Blueberry consumption specifically is associated with increased BDNF in older adults in several RCTs, likely through a combination of anthocyanin-mediated TrkB activation and antioxidant reduction of BDNF-suppressive inflammation.

Magnesium L-threonate does not directly increase BDNF protein but supports synaptic density and NMDA receptor function, complementing and extending the effects of BDNF-driven plasticity. Several studies show magnesium threonate improves synaptic plasticity markers that overlap mechanistically with BDNF function.

7. Peptide Research

Several neuroprotective peptides are under investigation for mechanisms that intersect with BDNF signalling and neuroplasticity. Most directly, Semax — a synthetic ACTH-derived heptapeptide — has demonstrated measurable upregulation of BDNF and TrkB mRNA in hippocampal and cortical tissue in preclinical studies, making it the peptide with the most direct evidence for influencing the BDNF pathway; the full research profile is covered in the article on Semax and cognitive performance. Dihexa, an angiotensin-derived peptidomimetic, takes a distinct route to BDNF upregulation — potentiating the HGF/Met receptor axis, which in turn stimulates BDNF expression as a downstream effect of Met phosphorylation; the full mechanistic profile is covered in the Dihexa research overview. Other peptides studied for their effects on nerve growth, hippocampal function, and synaptic protein synthesis remain in preclinical or early clinical stages of research.

8. Sunlight and Vitamin D

Vitamin D receptors (VDRs) are expressed throughout the hippocampus and prefrontal cortex. VDR activation directly upregulates the BDNF gene promoter — the vitamin D response element (VDRE) in the BDNF promoter region binds the activated VDR/RXR complex and increases BDNF transcription. Population studies consistently show that vitamin D deficiency is associated with lower serum BDNF and higher rates of depression and cognitive decline.

In Australia, vitamin D deficiency is more common than often assumed, particularly in individuals with darker skin tones, those who work indoors, or those living in southern states during winter. Optimal serum 25(OH)D for neurological function appears to be in the 100–150 nmol/L range based on current evidence — considerably higher than the conventional sufficiency threshold of 50 nmol/L used for bone health.

Morning sunlight exposure (30–45 minutes within 2 hours of sunrise) also entrains circadian rhythm, which independently supports deep sleep and the BDNF synthesis that occurs within it.

9. Stress Reduction and Mindfulness

Given that chronic cortisol is the most potent known suppressor of BDNF, any intervention that durably reduces cortisol and perceived stress will disinhibit BDNF expression. Mindfulness-Based Stress Reduction (MBSR) — an 8-week structured programme of meditation and body-scan practice — has been shown in RCTs to increase serum BDNF compared to waitlist controls, with the increase correlating with reductions in cortisol and perceived stress scores.

The mechanism is straightforward: sustained practice downregulates HPA (hypothalamic-pituitary-adrenal) axis reactivity, reducing basal cortisol, which removes its transcriptional suppression of BDNF. Regular practice also increases grey matter density in the hippocampus and prefrontal cortex — consistent with BDNF-mediated neuroplasticity.

BDNF and Psychiatric and Neurological Conditions

Depression

The neurotrophic hypothesis of depression positions inadequate BDNF signalling not merely as a consequence of depression but as a causal contributor. Supporting evidence includes:

The Val66Met BDNF polymorphism (reduced activity-dependent BDNF secretion) confers increased risk of depression and anxiety
Serum BDNF is reduced in proportion to depression severity and normalises with successful treatment
All major classes of antidepressant increase hippocampal BDNF — the time course of this increase (2–4 weeks) matches the clinical lag before antidepressant effect
Ketamine, which produces antidepressant effects within hours, triggers rapid BDNF-TrkB signalling through a distinct mechanism (AMPA receptor potentiation → rapid BDNF release), explaining its unusually fast onset

PTSD

Post-traumatic stress disorder is associated with lower serum BDNF, reduced hippocampal volume, and impaired fear extinction — all consistent with inadequate BDNF-dependent neuroplasticity. The hippocampal volume reduction in PTSD is strikingly similar to that seen in chronic depression and correlates with BDNF levels. Effective PTSD treatments, including trauma-focused CBT and EMDR, are associated with BDNF increases and hippocampal volume recovery over time.

Cognitive Decline and Alzheimer's Disease

BDNF reduction is an early feature of Alzheimer's disease, detectable in cerebrospinal fluid before significant cognitive symptoms emerge. Reduced BDNF-TrkB signalling impairs several processes central to Alzheimer's pathology: amyloid-beta clearance, tau kinase regulation, and synaptic protein maintenance. Animal models receiving BDNF gene therapy or TrkB agonists show significant improvements in memory performance and reduced amyloid burden.

The TrkB receptor agonist class of drugs is among the most actively developed in Alzheimer's drug pipelines — partly explaining the enormous scientific and commercial interest in natural BDNF-upregulating interventions as preventive strategies.

Measuring BDNF

Serum BDNF testing is available through private pathology providers in Australia, including NutriPATH and PathCare. This measures BDNF released from platelets during clotting, which is an imperfect but reasonably correlated proxy for brain BDNF levels — cross-sectional studies show serum and CSF BDNF levels track together at the population level.

Reference considerations:

Serum BDNF levels are highly variable between labs depending on assay methodology — use the same laboratory for longitudinal comparisons
Values are influenced by time of day (highest in the morning), recent exercise, and blood draw technique
A baseline test followed by a repeat at 8–12 weeks after implementing a structured intervention is a reasonable way to assess individual response
Typical reference ranges in adults: approximately 8–30 ng/mL in serum, though this varies by laboratory

While serum BDNF is not a precise neurodiagnostic tool, it provides a useful directional biomarker for tracking lifestyle intervention response at an individual level.

A Practical BDNF Optimisation Protocol

Combining the strongest evidence-based interventions into a coherent daily and weekly structure:

Daily foundations:

Morning sunlight, 30–45 minutes within 2 hours of sunrise
7–9 hours sleep, prioritising sleep architecture (consistent timing, cool room, no alcohol)
Omega-3 DHA 2g/day (fish oil or algal oil)
Lion's Mane extract 1g/day (fruiting body or dual extract)
Cold shower 2–3 minutes to end

4 days per week:

Zone 2 cardio, 35–45 minutes per session (cycling, running, rowing, swimming at conversational pace)

3–4 days per week:

16:8 intermittent fasting; ideally on exercise days to combine fasted Zone 2 for an amplified effect

Dietary priorities:

Increase polyphenol intake: blueberries, dark chocolate, green tea, olive oil
Curcumin with piperine or a bioavailable formulation
Prioritise whole foods; reduce ultra-processed foods and added sugars

Stress management:

10–15 minutes daily mindfulness or meditation
Address chronic stressors directly; see chronic stress and cortisol damage to the hippocampus for the full mechanistic case

This protocol targets brain-derived neurotrophic factor through multiple independent pathways simultaneously — exercise-induced irisin, fasting-induced AMPK/BHB, sleep-dependent synthesis, cortisol reduction, dietary TrkB support, and NGF/BDNF upregulation via Lion's Mane. The additive effect of stacking complementary mechanisms is likely substantially greater than any single intervention in isolation.

Frequently Asked Questions

What does BDNF do in the brain?

Brain-derived neurotrophic factor serves as the brain's primary growth and maintenance signal. It promotes the survival of existing neurons by blocking apoptosis, drives adult hippocampal neurogenesis (the formation of new neurons), strengthens synaptic connections through long-term potentiation, and regulates mood by supporting the neural circuits disrupted in depression and anxiety. In short, BDNF is what allows the brain to adapt, learn, recover, and maintain its structural integrity across a lifetime.

How can you increase BDNF naturally?

The most effective natural interventions for increasing brain-derived neurotrophic factor are aerobic exercise (particularly Zone 2 cardio, 3–4 times per week), intermittent fasting, optimising sleep quality and duration, reducing chronic stress, and morning sunlight exposure to support vitamin D synthesis. Dietary interventions — omega-3 DHA, curcumin, polyphenols — provide additional support. Lion's Mane mushroom is the best-evidenced supplement for neurotrophin upregulation, working primarily through NGF with downstream effects on BDNF. Stacking multiple complementary strategies produces the greatest sustained elevation.

Can you supplement BDNF directly?

No. BDNF is a protein and does not cross the blood-brain barrier when administered orally or intravenously. Oral BDNF supplements are not physiologically active — the protein is degraded in the gastrointestinal tract before absorption, and even if absorbed intact, could not cross the BBB. The practical approach is to stimulate the brain's own BDNF production through the lifestyle and dietary interventions described above. Intranasal and intrathecal BDNF delivery are being explored in clinical research settings, but these are investigational routes not available for general use.

Does exercise really increase BDNF?

Yes — this is one of the most replicated findings in exercise neuroscience. The acute increase in serum BDNF following a single bout of moderate-to-vigorous aerobic exercise (typically 20–45 minutes) has been demonstrated in dozens of studies across varied populations. Chronic training increases resting baseline levels and, in humans, produces measurable hippocampal volume expansion in randomised controlled trials — an outcome attributed largely to BDNF-driven neurogenesis and synaptic growth. The mechanism (lactate → PGC-1α → FNDC5/irisin → hippocampal BDNF) is well established in both animal and human research.